Ingunn Thorsteinsdottir1, Thor Aspelund2, Elias Gudmundsson3, Gudny Eiriksdottir3, Tamara B Harris4, Lenore J Launer4, Vilmundur Gudnason2, Per Venge5. 1. Icelandic Heart Association Research Institute, Kopavogur, Iceland; Department of Clinical Biochemistry, Landspitali University Hospital, Reykjavik, Iceland; 2. Icelandic Heart Association Research Institute, Kopavogur, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; 3. Icelandic Heart Association Research Institute, Kopavogur, Iceland; 4. Laboratory of Epidemiology, Demography and Biometry, Intramural Research Program, National Institute on Aging Bethesda, MD; 5. Department of Medical Sciences, Uppsala University, Uppsala, Sweden. per.venge@medsci.uu.se.
Abstract
BACKGROUND: The objective of this study was to investigate the predictive power of a high-sensitivity cardiac troponin I (hs-cTnI) assay for cardiovascular events and mortality in a large population of older community dwellers. METHODS: Blood was collected from 5764 individuals (age 66-98 years) during the period of 2002-2006 and the outcome as to all-cause death and incidence of cardiovascular disease (CVD) and coronary heart disease (CHD) followed up to 10 years. hs-cTnI (Abbott) was measured in serum to assess the association of this marker with CVD, CHD and death, and finally, to compare the results with conventional risk factors by multivariable statistical analysis. RESULTS: The median (interquartile range) concentrations of hs-cTnI were 8.4 ng/L (5.6-14.2 ng/L) and 5.3 ng/L (3.8-8.1 ng/L) in men (2416) and women (3275), respectively, and the concentrations increased linearly with age. Outcomes as to all-cause death and incidence of CVD and CHD were significantly associated with increasing concentrations of hs-cTnI beginning well below the 99th percentile concentrations. The associations with outcome remained after adjustments for conventional risk factors and were similar in men and women. CONCLUSIONS: Our findings suggest that hs-cTnI reflects the status of the myocardium even in seemingly healthy individuals and that the measurements of hs-cTnI may be useful for primary prediction of heart disease; this should form the basis for future prospective clinical trials for determining whether measuring hs-cTnI can be used in the prevention of CVD/CHD.
BACKGROUND: The objective of this study was to investigate the predictive power of a high-sensitivity cardiac troponin I (hs-cTnI) assay for cardiovascular events and mortality in a large population of older community dwellers. METHODS: Blood was collected from 5764 individuals (age 66-98 years) during the period of 2002-2006 and the outcome as to all-cause death and incidence of cardiovascular disease (CVD) and coronary heart disease (CHD) followed up to 10 years. hs-cTnI (Abbott) was measured in serum to assess the association of this marker with CVD, CHD and death, and finally, to compare the results with conventional risk factors by multivariable statistical analysis. RESULTS: The median (interquartile range) concentrations of hs-cTnI were 8.4 ng/L (5.6-14.2 ng/L) and 5.3 ng/L (3.8-8.1 ng/L) in men (2416) and women (3275), respectively, and the concentrations increased linearly with age. Outcomes as to all-cause death and incidence of CVD and CHD were significantly associated with increasing concentrations of hs-cTnI beginning well below the 99th percentile concentrations. The associations with outcome remained after adjustments for conventional risk factors and were similar in men and women. CONCLUSIONS: Our findings suggest that hs-cTnI reflects the status of the myocardium even in seemingly healthy individuals and that the measurements of hs-cTnI may be useful for primary prediction of heart disease; this should form the basis for future prospective clinical trials for determining whether measuring hs-cTnI can be used in the prevention of CVD/CHD.
Authors: Christopher R deFilippi; James A de Lemos; Robert H Christenson; John S Gottdiener; Willem J Kop; Min Zhan; Stephen L Seliger Journal: JAMA Date: 2010-11-15 Impact factor: 56.272
Authors: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith Journal: Circulation Date: 2011-03-28 Impact factor: 29.690
Authors: Kai M Eggers; Jinan Al-Shakarchi; Lars Berglund; Bertil Lindahl; Agneta Siegbahn; Lars Wallentin; Björn Zethelius Journal: Am Heart J Date: 2013-08-13 Impact factor: 4.749
Authors: Justin T Saunders; Vijay Nambi; James A de Lemos; Lloyd E Chambless; Salim S Virani; Eric Boerwinkle; Ron C Hoogeveen; Xiaoxi Liu; Brad C Astor; Thomas H Mosley; Aaron R Folsom; Gerardo Heiss; Josef Coresh; Christie M Ballantyne Journal: Circulation Date: 2011-03-21 Impact factor: 29.690
Authors: Nina Johnston; Tomas Jernberg; Bertil Lindahl; Johan Lindbäck; Mats Stridsberg; Anders Larsson; Per Venge; Lars Wallentin Journal: Clin Biochem Date: 2004-03 Impact factor: 3.281
Authors: Xiaoming Jia; Wensheng Sun; Ron C Hoogeveen; Vijay Nambi; Kunihiro Matsushita; Aaron R Folsom; Gerardo Heiss; David J Couper; Scott D Solomon; Eric Boerwinkle; Amil Shah; Elizabeth Selvin; James A de Lemos; Christie M Ballantyne Journal: Circulation Date: 2019-04-29 Impact factor: 29.690
Authors: Noreen van der Linden; Lieke J J Klinkenberg; Otto Bekers; Luc J C van Loon; Marja P van Dieijen-Visser; Maurice P Zeegers; Steven J R Meex Journal: Medicine (Baltimore) Date: 2016-12 Impact factor: 1.889
Authors: Peter Willeit; Paul Welsh; Jonathan D W Evans; Lena Tschiderer; Charles Boachie; J Wouter Jukema; Ian Ford; Stella Trompet; David J Stott; Patricia M Kearney; Simon P Mooijaart; Stefan Kiechl; Emanuele Di Angelantonio; Naveed Sattar Journal: J Am Coll Cardiol Date: 2017-08-01 Impact factor: 24.094
Authors: Dorien M Kimenai; Remy J H Martens; Jeroen P Kooman; Coen D A Stehouwer; Frans E S Tan; Nicolaas C Schaper; Pieter C Dagnelie; Miranda T Schram; Carla J H van der Kallen; Simone J S Sep; Jeroen D E van Suijlen; Abraham A Kroon; Otto Bekers; Marja P van Dieijen-Visser; Ronald M A Henry; Steven J R Meex Journal: Sci Rep Date: 2017-07-26 Impact factor: 4.379
Authors: Mark J Hamilton; Yvonne Robb; Sarah Cumming; Helen Gregory; Alexis Duncan; Monika Rahman; Anne McKeown; Catherine McWilliam; John Dean; Alison Wilcox; Maria E Farrugia; Anneli Cooper; Josephine McGhie; Berit Adam; Richard Petty; Cheryl Longman; Iain Findlay; Alan Japp; Darren G Monckton; Martin A Denvir Journal: PLoS One Date: 2017-03-21 Impact factor: 3.240
Authors: Mark Mariathas; Rick Allan; Sanjay Ramamoorthy; Bartosz Olechowski; Jonathan Hinton; Martin Azor; Zoe Nicholas; Alison Calver; Simon Corbett; Michael Mahmoudi; John Rawlins; Iain Simpson; James Wilkinson; Chun Shing Kwok; Paul Cook; Mamas A Mamas; Nick Curzen Journal: BMJ Date: 2019-03-13
Authors: Dorien M Kimenai; Anoop S V Shah; David A McAllister; Kuan Ken Lee; Athanasios Tsanas; Steven J R Meex; David J Porteous; Caroline Hayward; Archie Campbell; Naveed Sattar; Nicholas L Mills; Paul Welsh Journal: Clin Chem Date: 2021-10-01 Impact factor: 12.167